A detailed history of Intech Investment Management LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 103,539 shares of FOLD stock, worth $981,549. This represents 0.01% of its overall portfolio holdings.

Number of Shares
103,539
Previous 123,015 15.83%
Holding current value
$981,549
Previous $704,000 15.77%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$5.84 - $8.57 $113,739 - $166,909
-19,476 Reduced 15.83%
103,539 $815,000
Q2 2025

Aug 08, 2025

SELL
$5.64 - $8.0 $270,195 - $383,256
-47,907 Reduced 28.03%
123,015 $704,000
Q1 2025

May 20, 2025

BUY
$8.16 - $9.85 $377,138 - $455,247
46,218 Added 37.06%
170,922 $1.39 Million
Q4 2024

Feb 10, 2025

BUY
$9.36 - $12.01 $436,484 - $560,062
46,633 Added 59.73%
124,704 $1.17 Million
Q3 2024

Nov 08, 2024

BUY
$9.55 - $12.09 $745,578 - $943,878
78,071 New
78,071 $833,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.66B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.